3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Stomach Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Intraocular Lymphoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Cisplatin
75
Cetuximab
63
Radiotherapy
38
pembrolizumab
29
Radiotherapy, Intensity-Modulated
28
Carboplatin
25
Fluorouracil
24
Docetaxel
24
Paclitaxel
19
Erlotinib Hydrochloride
13
Nivolumab
12
Radiation
10
Pemetrexed
10
durvalumab
8
Gemcitabine
8
Drug Therapy
8
Bevacizumab
7
zalutumumab
6
Surgical Procedures, Operative
6
Panitumumab
6
Lapatinib
6
Everolimus
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
epacadostat
5
Standard of Care
5
Oxaliplatin
5
Gefitinib
5
Afatinib
5
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Head and Neck Neoplasms
×
oblimersen
×
Clear all
No trials found.